{"id":"W3041373504","doi":"10.1038/s41598-020-68017-y","title":"Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles","year":2020,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":283,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institute on Aging; National Institutes of Health","keywords":"Doxorubicin; Cytotoxicity; Chemistry; Iron oxide nanoparticles; Drug delivery; Pharmacology; Downregulation and upregulation; Cancer research; Apoptosis; Drug carrier; Blood–brain barrier; In vitro; Medicine; Chemotherapy; Biochemistry; Iron oxide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001555068,0.0004627606,0.0004285349,0.0003830211,0.0001132436,0.0002350957,0.0002580376,0.0003678841,0.0004092234],"category_scores_gemma":[0.00007021127,0.0001546548,0.0002785468,0.0001777562,0.0001271637,0.0002365186,0.00024613,0.0002999084,0.0001634971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003292641,"about_ca_system_score_gemma":0.0001533583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000407728,"about_ca_topic_score_gemma":0.0009202593,"domain_scores_codex":[0.9999088,0.00001347498,0.000006938219,0.0000251707,0.00002808647,0.00001746117],"domain_scores_gemma":[0.999977,0.000002720781,0.000006445714,0.000002362154,0.000004963866,0.000006502807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001706983,0.0001272095,0.0001453186,0.0001591805,0.00002669651,0.0001177665,0.00001681149,0.0004097802,0.9795624,0.0002292071,0.0002191272,0.01881569],"study_design_scores_gemma":[0.0001265548,0.001536325,0.001317928,0.00001950091,0.0001321564,0.0007951397,0.00001243922,0.007023913,0.9775408,0.00008506622,0.01138246,0.00002779149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9157975,0.02706681,0.04895002,0.0005418641,0.0003253317,0.0005097104,0.0001969811,0.0003186704,0.006293205],"genre_scores_gemma":[0.9696871,0.007311621,0.01843466,0.0001508038,0.00007259842,0.000197403,0.0001499209,0.0000273781,0.003968513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0004627606,"threshold_uncertainty_score":0.002389014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02313712323556881,"score_gpt":0.2428613238154785,"score_spread":0.2197242005799097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}